Do antipsychotics raise breast cancer risk? A new study suggests that long-term use of prolactin-raising antipsychotics may increase that risk in women with severe mental illness. We review the findings, highlight which medications pose greater concern, and offer guidance on monitoring, screening, and prescribing safer alternatives when appropriate.

A new digital tool helps clinicians compare psychiatric medications based on side effect profiles—streamlining complex decisions with data from dozens of major studies and treatment guidelines.

Guanfacine is a popular second-line treatment for ADHD in children and teens. But what happens as our patients age into adulthood? Does guanfacine remain an effective medication in adults with ADHD? This research update covers a study that tries to answer this question.

Research explores the kidney injury risks associated with lithium compared to valproate, revealing unexpected findings.

Most of us use methylphenidate (MPH) routinely in patients across a wide range of ages and even diagnoses. But what are the long-term side effects of MPH? This research update gives you a current understanding of the potential risks with helpful guidance on how to proceed with care.